Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma
about
New molecular targets in mantle cell lymphomaThe B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignanciesNovel agents in mantle cell lymphomaInhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma.Molecular targeted approaches in mantle cell lymphoma.High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphomaMolecular pathogenesis of mantle cell lymphoma.Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma.Bortezomib for the treatment of non-Hodgkin's lymphomaBortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells.Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphomaImmune modulatory nanoparticle therapeutics for intracerebral glioma.Bortezomib: A Review in Mantle Cell Lymphoma in Previously Untreated Patients Unsuitable for Stem-Cell Transplantation.Ibrutinib for mantle cell lymphoma.Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma.Gene methylation and silencing of SOCS3 in mantle cell lymphoma.P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell linesNovel agents in mantle cell lymphoma.Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.Involvement of mitogen-activated protein kinase in signal transducer and activator of transcription-1 mediated differentiation induced by bortezomib in acute myeloid leukemia cells.Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.Template-switching anchored polymerase chain reaction reliably amplifies functional lambda light chain transcripts of malignant lymphoma.Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patienB Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment.The molecular pathogenesis of mantle cell lymphoma.Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged Mice.
P2860
Q26821766-1297748A-34A6-42E2-941F-5031A820930FQ26822700-AAC404C2-4362-47D1-BF49-45FBB91EF7DEQ27011763-2A15F530-991E-47F1-9875-53151DDBFF8EQ34042407-37BD1A81-6774-4187-82A1-479EB2B8F65FQ35127368-8354B25F-AE03-40AA-9D31-6BF1FA250510Q35186102-999D687C-FCCF-4CF6-9D6E-D0688EB5EF31Q36290246-17C2E567-670C-4645-9619-1587901F1A9CQ36370860-F6D2E4FB-BF88-4184-87A4-A275863CCC32Q36546004-D5596F98-901A-4C6F-9AF8-3D7E01241086Q36649225-3535082F-D6D3-4F7B-AAD8-DFE0DB844212Q36868056-AF5BF59F-6B40-4FF5-8E10-DF3765D513BDQ37280039-A7AFCA6B-51B9-4B1E-89A9-2F5C78BCA731Q37731677-2271AB6B-B95E-4680-9AE4-7FB0D29A76E1Q38409605-0B0EE276-2FB7-44EE-924A-3EE51F380F23Q38538693-DCC5CD8B-C6D9-4755-9261-49B82E66254EQ38694168-0EE89330-AC20-44BE-879C-7D4FF49AD893Q38810148-A539547F-2222-4FA2-96F0-2D92958E9626Q38847015-F500EBD1-DAD6-4F22-A5D4-905F0A319D98Q38957093-BF4E9AB2-B3FA-46F4-8685-AADB4C0E8D1CQ39190247-52BD0786-5C44-4153-B6CB-555F5D4D8F36Q39257616-FFF7D8F3-73D4-4C20-A700-F35BDE3540DCQ39290199-1C014D7C-C031-46DE-B00A-3FC7989F369BQ42230312-4B6D6FE9-47E0-41BB-B203-3E308709E28AQ44324034-95484A35-FD63-474D-A860-6509CB571C2CQ47116206-F374AEC7-F56A-4061-AE3F-4C11F4D67E8BQ47937234-655EED4A-2256-4028-AA91-E9A48F80E0D5Q49959959-BE16F763-E6C5-4913-96D8-6258E089660DQ50056654-12289DCE-2EFB-4D99-AA2A-21C944EC6312Q53260519-D0CEA9F1-94B9-4877-B5E9-D2D7B458CEE4Q53730905-54E52907-322E-415F-A2B5-2E8B8D8D59D1Q55007581-2E12FC30-B3EC-44CA-8D7A-59CAC3B38CCDQ55511985-34D56D83-C820-4791-834D-E985A721CF43
P2860
Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@ast
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@en
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@nl
type
label
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@ast
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@en
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@nl
prefLabel
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@ast
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@en
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@nl
P2093
P2860
P1433
P1476
Constitutive and B-cell recept ...... leukemic mantle cell lymphoma
@en
P2093
Antoine Martin
Claudine Roger
Dominique Ledoux
Fanny Baran-Marszak
Florence Ajchenbaum-Cymbalista
Mohand Boukhiar
Nadine Varin-Blank
Remi Fagard
Stéphanie Harel
P2860
P304
P356
10.3324/HAEMATOL.2009.019745
P577
2010-07-27T00:00:00Z